207 related articles for article (PubMed ID: 34804925)
1. Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma.
Liu R; Shen Y; Hu J; Wang X; Wu D; Zhai M; Bai J; He A
Front Oncol; 2021; 11():731957. PubMed ID: 34804925
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
4. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
5. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.
Jia Y; Liu R; Shi L; Feng Y; Zhang L; Guo N; He A; Kong G
BMC Cancer; 2023 Sep; 23(1):859. PubMed ID: 37700273
[TBL] [Abstract][Full Text] [Related]
7. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma.
Wang J; Zuo Y; Lv C; Zhou M; Wan Y
IUBMB Life; 2023 Feb; 75(2):137-148. PubMed ID: 36177774
[TBL] [Abstract][Full Text] [Related]
9. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment.
He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S
Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
Chen D; Guo W; Yu H; Yang J
Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
14. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma.
Wang Z; Cheng H; Xu H; Yu X; Sui D
Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634
[TBL] [Abstract][Full Text] [Related]
15. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme.
Wang LC; Chen SH; Shen XL; Li DC; Liu HY; Ji YL; Li M; Yu K; Yang H; Chen JJ; Qin CZ; Luo MM; Lin QX; Lv QL
Front Oncol; 2020; 10():536875. PubMed ID: 33134160
[TBL] [Abstract][Full Text] [Related]
16. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
17. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
18. m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer.
Sheng G; Wang T; Gao Y; Wu H; Wu J
Sci Rep; 2023 Nov; 13(1):19670. PubMed ID: 37952076
[TBL] [Abstract][Full Text] [Related]
19. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
20. A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms.
Chen X; Mo S; Zong L; Yu S; Lu Z; Chen J
Neuroendocrinology; 2022; 112(12):1187-1199. PubMed ID: 35609514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]